Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
Advances in Neurology
|
January 1, 1993
Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals
C R Freed, R E Breeze, N L Rosenberg, et al.
Journal of Speech, Language, and Hearing Research : JSLHR
|
June 1, 1997
Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease
K K Baker, L O Ramig, A B Johnson, et al.
Journal of Neural Transplantation & Plasticity
|
April 1, 1993
Trained and amphetamine-induced circling behavior in lesioned, transplanted rats
J B Richards, K E Sabol, E H Kriek, et al.
Cell Transplantation
|
May 20, 1998
Immunological responses to injury and grafting in the central nervous system of nonhuman primates
R A Bakay, K L Boyer, C R Freed, et al.
Brain Research
|
May 29, 2000
Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells
W Zhou, M S Hurlbert, J Schaack, et al.
Cell Transplantation
|
May 25, 1999
Neural transplantation of hNT neurons for Huntington's disease
M S Hurlbert, R I Gianani, C Hutt, et al.
JAMA
|
April 13, 1979
Hemoperfusion in drug overdose
C R Freed, J G Gerber, J Gal, et al.
Experimental Neurology
|
July 1, 1996
Growth factors rescue embryonic dopamine neurons from programmed cell death
W M Zawada, D L Kirschman, J J Cohen, et al.
Brain Research
|
September 18, 1998
Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats
E D Clarkson, W M Zawada, F S Adams, et al.
Brain Research Bulletin
|
March 16, 2000
Co-grafts of muscle cells and mesencephalic tissue into hemiparkinsonian rats: behavioral and histochemical effects
F G Kaddis, E D Clarkson, K P Bell, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
Advances in Neurology
|
January 1, 1993
Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals
C R Freed, R E Breeze, N L Rosenberg, et al.
Journal of Speech, Language, and Hearing Research : JSLHR
|
June 1, 1997
Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease
K K Baker, L O Ramig, A B Johnson, et al.
Journal of Neural Transplantation & Plasticity
|
April 1, 1993
Trained and amphetamine-induced circling behavior in lesioned, transplanted rats
J B Richards, K E Sabol, E H Kriek, et al.
Cell Transplantation
|
May 20, 1998
Immunological responses to injury and grafting in the central nervous system of nonhuman primates
R A Bakay, K L Boyer, C R Freed, et al.
Brain Research
|
May 29, 2000
Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells
W Zhou, M S Hurlbert, J Schaack, et al.
Cell Transplantation
|
May 25, 1999
Neural transplantation of hNT neurons for Huntington's disease
M S Hurlbert, R I Gianani, C Hutt, et al.
JAMA
|
April 13, 1979
Hemoperfusion in drug overdose
C R Freed, J G Gerber, J Gal, et al.
Experimental Neurology
|
July 1, 1996
Growth factors rescue embryonic dopamine neurons from programmed cell death
W M Zawada, D L Kirschman, J J Cohen, et al.
Brain Research
|
September 18, 1998
Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats
E D Clarkson, W M Zawada, F S Adams, et al.
Brain Research Bulletin
|
March 16, 2000
Co-grafts of muscle cells and mesencephalic tissue into hemiparkinsonian rats: behavioral and histochemical effects
F G Kaddis, E D Clarkson, K P Bell, et al.
Page
of 10